61.90
price down icon11.58%   -8.11
pre-market  Pre-market:  62.70   0.80   +1.29%
loading
Conmed Corp. stock is currently priced at $61.90, with a 24-hour trading volume of 2.60M. It has seen a -11.58% decreased in the last 24 hours and a -19.25% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $70.52 pivot point. If it approaches the $67.28 support level, significant changes may occur.
Previous Close:
$70.01
Open:
$63.37
24h Volume:
2.60M
Market Cap:
$1.91B
Revenue:
$1.24B
Net Income/Loss:
$64.46M
P/E Ratio:
33.46
EPS:
1.85
Net Cash Flow:
$106.32M
1W Performance:
-12.92%
1M Performance:
-19.25%
6M Performance:
-32.48%
1Y Performance:
-46.28%
1D Range:
Value
$61.05
$65.94
52W Range:
Value
$61.05
$138.47

Conmed Corp. Stock (CNMD) Company Profile

Name
Name
Conmed Corp.
Name
Phone
315 797 8375
Name
Address
525 French Road, Utica, NY
Name
Employee
3,300
Name
Twitter
@ConMedLinvatec
Name
Next Earnings Date
2024-05-23
Name
Latest SEC Filings
Name
CNMD's Discussions on Twitter

Conmed Corp. Stock (CNMD) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-01-24 Reiterated Needham Buy
May-22-23 Initiated CL King Buy
Mar-27-23 Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Mar-21-23 Initiated Wells Fargo Equal Weight
Oct-12-22 Initiated Jefferies Hold
Mar-02-22 Resumed BofA Securities Neutral
Oct-06-21 Upgrade Needham Hold → Buy
Jul-15-21 Initiated UBS Buy
May-25-21 Initiated Barclays Overweight
Nov-26-19 Downgrade Needham Buy → Hold
Nov-12-19 Initiated JP Morgan Overweight
Oct-31-19 Reiterated Needham Buy
Oct-04-19 Reiterated Needham Buy
Aug-22-19 Upgrade Piper Jaffray Neutral → Overweight
Apr-18-19 Initiated Stifel Buy
Apr-16-19 Reiterated Needham Buy
Jan-23-19 Reiterated Needham Buy
Oct-16-18 Initiated Barclays Equal Weight
Aug-07-18 Reiterated Needham Buy
Aug-02-18 Reiterated Needham Buy
Apr-26-18 Reiterated Needham Buy
Feb-01-18 Reiterated Needham Buy
Jul-27-17 Reiterated Needham Buy
Apr-27-17 Downgrade Ladenburg Thalmann Buy → Neutral
Apr-27-17 Reiterated Needham Buy
Nov-18-16 Reiterated Needham Buy
Jul-28-16 Downgrade Leerink Partners Outperform → Mkt Perform
Apr-28-16 Reiterated Needham Buy
Oct-22-15 Reiterated Northland Capital Market Perform
View All

Conmed Corp. Stock (CNMD) Financials Data

Conmed Corp. (CNMD) Revenue 2024

CNMD reported a revenue (TTM) of $1.24 billion for the quarter ending December 31, 2023, a +19.06% rise year-over-year.
loading

Conmed Corp. (CNMD) Net Income 2024

CNMD net income (TTM) was $64.46 million for the quarter ending December 31, 2023, a +179.99% increase year-over-year.
loading

Conmed Corp. (CNMD) Cash Flow 2024

CNMD recorded a free cash flow (TTM) of $106.32 million for the quarter ending December 31, 2023, a +818.10% increase year-over-year.
loading

Conmed Corp. (CNMD) Earnings per Share 2024

CNMD earnings per share (TTM) was $2.04 for the quarter ending December 31, 2023, a +171.83% growth year-over-year.
loading
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. The company offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. It offers orthopedic surgery products under Hall, CONMED Linvatec, Concept, and Shutt brands. The company also offers general surgery product in the areas of advanced surgical comprising clinical insufflation system; electrosurgical products; and endomechanical products comprising instruments, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors. In addition, it offers endoscopic technologies offering, including diagnostic and therapeutic products for use in gastroenterology procedures; cardiology and critical care products cover a line of vital signs, cardiac monitoring, and patient care products, including ECG electrodes and accessories, cardiac defibrillation and pacing pads, and suction instruments and tubing; and physician's office electrosurgical product used by dermatologists. The company markets its products directly to surgeons, hospitals, surgery centers, group purchasing organizations, integrated delivery networks, and other customers, as well as through medical specialty distributors. CONMED Corporation was founded in 1970 and is headquartered in Utica, New York.
medical_devices PHG
$20.72
price down icon 1.19%
medical_devices STE
$201.54
price down icon 0.62%
$310.50
price down icon 1.05%
medical_devices ZBH
$119.75
price down icon 1.17%
medical_devices EW
$88.01
price down icon 0.68%
$138.01
price up icon 0.10%
Cap:     |  Volume (24h):